Log In
person
Myovant Sciences Ltd
MYOV
summarize
2 total product lines
calendar_month
Revenue as of 03/31/2022
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biopharma |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
199.31M | 86.29% |
| Biopharma |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
31.67M | 13.71% |
| keyboard_arrow_down |
Biopharma
Branded Pharmaceuticals (outsourced)
|
199.31M | 86.29% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Biopharma
Pharmaceutical Patent Licensing
|
31.67M | 13.71% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||